ArticleJAMA network open2025
Passive Smartphone Sensors for Detecting Psychopathology.
Article in JAMA network open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed.
- A randomized controlled trial to address a multimodal intervention in the elderly: the effects of the CAMINN study.Aging clinical and experimental research · 2026Trial
- Validating an aphasia-accessible ecological momentary assessment for daily depressive affect: A preliminary investigation.Journal of affective disorders · 2026Article
- Advancing Dimensional Models of Psychopathology in Cancer: Insights From Applying the Hierarchical Taxonomy of Psychopathology (HiTOP).Psycho-oncology · 2026Article
- Article
- A multilevel meta-analysis of passive smartphone sensing of adolescent mental health.NPJ digital medicine · 2026Article
- Interindividual differences in digital phenotypes of major depressive disorder: A passive sensing study using smartphone and wearable sensor data.Behaviour research and therapy · 2026Article
- Setting digital psychiatry in motion: towards dynamic digital markers for digital phenotyping.NPP - digital psychiatry and neuroscience · 2026Review
- Cognitive arbitration between candidate dimensions of psychopathology.Molecular psychiatry · 2026Article
- Advancing Ambulatory Assessment Studies on Psychopathic Traits: A Response to Commentaries.Clinical psychological science : a journal of the Association for Psychological Science · 2025Article
- Identifying Time-Variant Predictors of Interest in Completing Brief Digital Mental Health Interventions Among Adult Survivors of Cancer: Ecological Momentary Assessment Study.JMIR mHealth and uHealth · 2025Observational
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Importance: Smartphone sensors can continuously and unobtrusively collect clinically relevant behavioral data, allowing for more precise symptom monitoring in clinical and research settings. However, progress in identifying unique behavioral markers of psychopathology from smartphone sensors has been stalled by research on diagnostic categories that are heterogenous and have many nonspecific symptoms. Objective: To examine which domains of psychopathology are detectable with smartphone sensors and identify passively sensed markers for general impairment (the p-factor) and specific transdiagnostic domains. Design, Setting, and Participants: This cross-sectional study collected data from the Intensive Longitudinal Investigation of Alternative Diagnostic Dimensions study from January 1 to December 31, 2023, including a baseline survey and 15 days of smartphone monitoring. Participants were recruited from the community via a clinical research registry. A volunteer sample was selected for mental health treatment status. Main Outcomes and Measures: Transdiagnostic psychopathology dimensions of internalizing, detachment, disinhibition, antagonism, thought disorder, somatoform, and the p-factor; 27 behavior markers derived from a global positioning system, accelerometer, motion, call logs, screen on or off, and battery status. Results: A total of 557 participants were included in the study (463 [83%] female; mean [SD] age, 30.7 [8.8] years). The coefficient of multiple correlation (R) showed that the domain most strongly correlated with sensed behavior was detachment (R = 0.42; 95% CI, 0.29-0.54) followed by somatoform (R = 0.41; 95% CI, 0.30-0.53), internalizing (R = 0.37), disinhibition (R = 0.35; 95% CI, 0.19-0.51), antagonism (R = 0.33; 95% CI, 0.6-0.59), and thought disorder (R = 0.28; 95% CI, -0.19 to 0.75). Each psychopathology domain was associated with 4 to 10 smartphone sensor variables. Detachment, somatoform, and internalizing had the most behavioral markers. Of the 27 smartphone sensor variables, 14 (52%) had associations with psychopathology domains. After adjusting for shared variance between psychopathology dimensions, all domains except thought disorder retained significant, incremental associations with sensor variables, reflecting unique behavioral signatures (eg, antagonism and number of calls [standardized β = -0.11; 95% CI, -0.20 to -0.02] and disinhibition and battery charge level [standardized β = -0.24; 95% CI, -0.40 to -0.08]). The p-factor was associated with lower mobility (standardized β = -0.22; 95% CI, -0.32 to -0.12), more time at home (standardized β = 0.23; 95% CI, 0.14 to 0.32), later bed time (standardized β = 0.25; 95% CI, 0.11 to 0.38), and less phone charge (standardized β = -0.16; 95% CI, -0.30 to -0.01]). The p-factor was modeled as a latent factor estimated from common variance of the 6 psychopathology domains. All domains loaded moderately to strongly onto the p-factor as expected (standardized loadings: 0.89 for internalizing, 0.76 for somatoform, 0.70 for disinhibition, 0.62 for thought disorder, 0.51 for detachment, and 0.40 for antagonism). Conclusions and Relevance: This cross-sectional study shows how tethering transdiagnostic domains to concrete behavioral markers can maximize the potential of mobile sensing to study mechanisms driving psychopathology. Insights from these results, and future research that builds on them, can potentially be translated into symptom monitoring tools that fill the gaps in current practice and may eventually lead to more precise and effective treatment.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.